Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.30%)
As of: Sep 3, 2026 · 2:44 PM EDT

Starling Oncology (STLN) Depreciation & Amortization - Total (2021 - 2026)

Analysis

Starling Oncology (STLN) Depreciation & Amortization - Total (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 HCA Healthcare 90.68 Bn 89.67 Bn 15.19 Bn -
2 Tenet Healthcare 22.03 Bn 19.86 Bn 4.45 Bn -
3 Encompass Health 12.07 Bn 11.93 Bn 1.34 Bn -
4 Davita 11.73 Bn 11.05 Bn 1.16 Bn -
5 Universal Health Services 10.15 Bn 10.01 Bn 3.29 Bn -
6 Ensign 9.95 Bn 9.63 Bn 306.24 Mn -
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 14.27 Mn
8 Pacs 6.68 Bn 6.51 Bn 338.46 Mn -
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn -
10 Starling Oncology 613.04 Mn 571.94 Mn 27.17 Mn 1.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.12 Mn
Mar 31, 2026 901,000.00
Dec 31, 2025 915,000.00
Sep 30, 2025 1.01 Mn
Jun 30, 2025 1.03 Mn
Mar 31, 2025 1.01 Mn
Dec 31, 2024 933,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 745,000.00
Mar 31, 2024 715,000.00
Dec 31, 2023 808,000.00
Sep 30, 2023 914,000.00
Jun 30, 2023 601,000.00
Mar 31, 2023 541,000.00
Dec 31, 2022 460,000.00
Sep 30, 2022 393,000.00
Jun 30, 2022 359,000.00
Mar 31, 2022 314,000.00
Dec 31, 2021 263,000.00
Sep 30, 2021 225,000.00